Clark, Joseph
Chang, Sungwon
Kinchin, Irina
Ferreira, Diana
Kochovska, Slavica
Morgan, Deidre
Poulos, Leanne M.
Johnson, Miriam J.
Ekström, Magnus
Currow, David C.
Funding for this research was provided by:
Discretionary fundsn/a
Article History
Received: 27 October 2021
Accepted: 13 December 2021
First Online: 18 March 2022
Declarations
:
: The study had ongoing approval by the Human Research Ethics Committees of the South Australian Department of Health and University of Adelaide (H-097-2010). Respondents provided informed verbal consent as interviews commenced, with participation accepted as ongoing consent.
: Not applicable.
: DCC is an unpaid member of an advisory board for Helsinn Pharmaceuticals and Specialist Therapeutics, and has consulted to, and received intellectual property payments from Mayne Pharma. MJJ has consulted to Mayne Pharma. Other authors have no conflicts to disclose.